Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Life Science Companies as Investments | Life Science Night Dec. 9, 2025

By Inderes

Antti Siltanen, Life Science Analyst, PhD, talks about life science companies as investments.


Life Science Night 2025

  • Keynote – Antti Siltanen, Inderes (link)
  • Orion Pharma – Tuukka Hirvonen, Head of Investor Relations (link)
  • Aiforia – Jukka Tapaninen, CEO (link)
  • Herantis Pharma – Antti Vuolanto, CEO (link)


Life Science Night December 9, 2025 (link)
Life Science Night December 2, 2024 (link)

Stay up to date
Aiforia Technologies
Bioretec
Biohit
Faron Pharmaceuticals
Modulight
Nexstim
Orion
Bittium
Detection Technology
Optomed
Revenio Group
Nightingale Health
Herantis Pharma
Nanoform Finland
Investor events

Recent videos

Agillic: CEO-interview oven på FY 2025-resultaterne
03.03.2026, 17.11 Agillic
Gubra - Præsentation af årsregnskabet for 2025
03.03.2026, 13.00 Gubra
Canatu, Webcast, Q4'25
03.03.2026, 11.00 Canatu
HCA Morgenbørs 03/03 - Store fald på stigende uro
03.03.2026, 09.18 D/S Norden
GrønlandsBANKEN – Præsentation af årsregnskabet 2025
02.03.2026, 11.00 Grønlandsbanken
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.